Our current research demonstrated that TRAF3IP3 could inhibit the proliferation of LUAD cells both in vitro and in vivo while leaving the ability of migration and invasion unaffected, which differs from melanoma and glioma. This evidence concerns the gene TRAF3IP3 and central nervous system cancer.